Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 126

1.

The Extracellular Matrix: Reloaded Revolutions.

Egesten A, Herwald H.

J Innate Immun. 2019;11(4):301-302. doi: 10.1159/000500357. Epub 2019 Jun 5. No abstract available.

2.

Osteopontin mediates murine transfusion-related acute lung injury via stimulation of pulmonary neutrophil accumulation.

Kapur R, Kasetty G, Rebetz J, Egesten A, Semple JW.

Blood. 2019 Jul 4;134(1):74-84. doi: 10.1182/blood.2019000972. Epub 2019 May 10.

PMID:
31076444
3.

Innate immunity - a clinical perspective.

Egesten A, Gordon S, Herwald H.

J Intern Med. 2019 May;285(5):477-478. doi: 10.1111/joim.12898. Epub 2019 Apr 16. No abstract available.

PMID:
30989770
4.

Another Brick in the Wall.

Herwald H, Egesten A.

J Innate Immun. 2019;11(2):109-110. doi: 10.1159/000498950. Epub 2019 Feb 26. No abstract available.

5.

Catch Me if You Can or Actors on the Run.

Egesten A, Herwald H.

J Innate Immun. 2019;11(1):1-2. doi: 10.1159/000495685. Epub 2018 Dec 11. No abstract available.

6.

Osteopontin protects against pneumococcal infection in a murine model of allergic airway inflammation.

Kasetty G, Bhongir RKV, Papareddy P, Tufvesson E, Stenberg H, Bjermer L, Hultgårdh-Nilsson A, Herwald H, Egesten A.

Allergy. 2019 Apr;74(4):663-674. doi: 10.1111/all.13646. Epub 2018 Nov 19.

PMID:
30362569
7.

Journal of Innate Immunity Ten Years Later.

Egesten A, Herwald H.

J Innate Immun. 2018;10(5-6):363-364. doi: 10.1159/000494683. Epub 2018 Oct 25. No abstract available.

8.

TFPI-2 Protects Against Gram-Negative Bacterial Infection.

Ali MN, Kasetty G, Elvén M, Alyafei S, Jovic S, Egesten A, Herwald H, Schmidtchen A, Papareddy P.

Front Immunol. 2018 Sep 11;9:2072. doi: 10.3389/fimmu.2018.02072. eCollection 2018.

9.

Osteopontin protects against lung injury caused by extracellular histones.

Kasetty G, Papareddy P, Bhongir RKV, Ali MN, Mori M, Wygrecka M, Erjefält JS, Hultgårdh-Nilsson A, Palmberg L, Herwald H, Egesten A.

Mucosal Immunol. 2019 Jan;12(1):39-50. doi: 10.1038/s41385-018-0079-3. Epub 2018 Aug 16.

PMID:
30115999
10.

Heparin-binding protein in sputum as a marker of pulmonary inflammation, lung function, and bacterial load in children with cystic fibrosis.

Hovold G, Palmcrantz V, Kahn F, Egesten A, Påhlman LI.

BMC Pulm Med. 2018 Jun 20;18(1):104. doi: 10.1186/s12890-018-0668-7.

11.

An ecoimmunological approach to study evolutionary and ancient links between coagulation, complement and Innate immunity.

Papareddy P, Kasetty G, Alyafei S, Smeds E, Salo-Ahen OMH, Hansson SR, Egesten A, Herwald H.

Virulence. 2018 Dec 31;9(1):724-737. doi: 10.1080/21505594.2018.1441589.

12.

The Nonantibiotic Macrolide EM703 Improves Survival in a Model of Quinolone-Treated Pseudomonas aeruginosa Airway Infection.

Kasetty G, Bhongir RKV, Papareddy P, Herwald H, Egesten A.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e02761-16. doi: 10.1128/AAC.02761-16. Print 2017 Sep.

13.

Visions and the Progress of Science.

Egesten A, Herwald H.

J Innate Immun. 2017;9(4):331-332. doi: 10.1159/000478280. Epub 2017 Jun 22. No abstract available.

14.

Cells of Innate and Adaptive Immunity: A Matter of Class?

Herwald H, Egesten A.

J Innate Immun. 2017;9(2):109-110. doi: 10.1159/000457176. Epub 2017 Feb 2. No abstract available.

15.

Coeliac disease and invasive pneumococcal disease: a population-based cohort study.

Röckert Tjernberg A, Bonnedahl J, Inghammar M, Egesten A, Kahlmeter G, Nauclér P, Henriques-Normark B, Ludvigsson JF.

Epidemiol Infect. 2017 Apr;145(6):1203-1209. doi: 10.1017/S0950268816003204. Epub 2017 Jan 23.

PMID:
28112068
16.

Intracellular Clearance by Nobel Laureates.

Herwald H, Egesten A.

J Innate Immun. 2017;9(1):1-2. doi: 10.1159/000453127. Epub 2016 Dec 7. No abstract available.

17.

DNA-fragmentation is a source of bactericidal activity against Pseudomonas aeruginosa.

Bhongir RK, Kasetty G, Papareddy P, Mörgelin M, Herwald H, Egesten A.

Biochem J. 2017 Feb 1;474(3):411-425. doi: 10.1042/BCJ20160706. Epub 2016 Oct 26.

PMID:
27784762
18.

On PAMPs and DAMPs.

Herwald H, Egesten A.

J Innate Immun. 2016;8(5):427-8. doi: 10.1159/000448437. Epub 2016 Aug 13. No abstract available.

19.

The Origin of a Paradigm.

Herwald H, Egesten A.

J Innate Immun. 2016;8(3):221-2. doi: 10.1159/000445282. Epub 2016 Apr 28. No abstract available.

20.

Gone with the Wind--Innate Immunity and Airway Inflammation.

Herwald H, Egesten A.

J Innate Immun. 2016;8(2):109-10. doi: 10.1159/000444614. Epub 2016 Mar 1. No abstract available.

21.

Roflumilast Increases Bacterial Load and Dissemination in a Model of Pseudomononas Aeruginosa Airway Infection.

Kasetty G, Papareddy P, Bhongir RK, Egesten A.

J Pharmacol Exp Ther. 2016 Apr;357(1):66-72. doi: 10.1124/jpet.115.229641. Epub 2016 Feb 10.

PMID:
26865680
22.

Osteopontin That Is Elevated in the Airways during COPD Impairs the Antibacterial Activity of Common Innate Antibiotics.

Gela A, Bhongir RK, Mori M, Keenan P, Mörgelin M, Erjefält JS, Herwald H, Egesten A, Kasetty G.

PLoS One. 2016 Jan 5;11(1):e0146192. doi: 10.1371/journal.pone.0146192. eCollection 2016.

23.

Incidence of stroke and stroke subtypes in chronic obstructive pulmonary disease.

Söderholm M, Inghammar M, Hedblad B, Egesten A, Engström G.

Eur J Epidemiol. 2016 Feb;31(2):159-68. doi: 10.1007/s10654-015-0113-7. Epub 2015 Dec 28.

PMID:
26711630
24.

Nobel Parasites in the Kingdom of Invertebrates.

Herwald H, Egesten A.

J Innate Immun. 2016;8(1):1-2. doi: 10.1159/000443137. Epub 2015 Dec 23. No abstract available.

25.

Extracellular Histones Induce Chemokine Production in Whole Blood Ex Vivo and Leukocyte Recruitment In Vivo.

Westman J, Papareddy P, Dahlgren MW, Chakrakodi B, Norrby-Teglund A, Smeds E, Linder A, Mörgelin M, Johansson-Lindbom B, Egesten A, Herwald H.

PLoS Pathog. 2015 Dec 8;11(12):e1005319. doi: 10.1371/journal.ppat.1005319. eCollection 2015 Dec.

26.

[Sepsis--the unknown public disease of our time].

Mellhammar L, Kander T, Christensson B, Herwald H, Egesten A, Larsson A, Sjölin J, Brink M, Mehle C, Hanberger H, Gårdlund B, Oldner A, Källman J, Linder A.

Lakartidningen. 2015 Nov 17;112. pii: DSAI. Swedish. No abstract available.

27.

Osteopontin binds and modulates functions of eosinophil-recruiting chemokines.

Gela A, Kasetty G, Mörgelin M, Bergqvist A, Erjefält JS, Pease JE, Egesten A.

Allergy. 2016 Jan;71(1):58-67. doi: 10.1111/all.12771. Epub 2015 Oct 20.

PMID:
26411293
28.

The Neutrophil: A Beautiful Beast or a Beastly Beauty?

Herwald H, Egesten A.

J Innate Immun. 2015;7(6):555-6. doi: 10.1159/000431055. Epub 2015 Sep 8. No abstract available.

29.

Back to the Present.

Herwald H, Egesten A.

J Innate Immun. 2015;7(5):441-2. doi: 10.1159/000433500. Epub 2015 Jun 30. No abstract available.

30.

Foodies of Innate Immunity.

Herwald H, Egesten A.

J Innate Immun. 2015;7(4):331-2. doi: 10.1159/000430800. Epub 2015 May 13. No abstract available.

31.

The neutrophil-recruiting chemokine GCP-2/CXCL6 is expressed in cystic fibrosis airways and retains its functional properties after binding to extracellular DNA.

Jovic S, Linge HM, Shikhagaie MM, Olin AI, Lannefors L, Erjefält JS, Mörgelin M, Egesten A.

Mucosal Immunol. 2016 Jan;9(1):112-23. doi: 10.1038/mi.2015.43. Epub 2015 May 20.

PMID:
25993443
32.

Collagen VI Is Upregulated in COPD and Serves Both as an Adhesive Target and a Bactericidal Barrier for Moraxella catarrhalis.

Abdillahi SM, Bober M, Nordin S, Hallgren O, Baumgarten M, Erjefält J, Westergren-Thorsson G, Bjermer L, Riesbeck K, Egesten A, Mörgelin M.

J Innate Immun. 2015;7(5):506-17. doi: 10.1159/000381213. Epub 2015 Apr 25.

33.

Hypoxia down-regulates expression of secretory leukocyte protease inhibitor in bronchial epithelial cells via TGF-β1.

Påhlman LI, Jögi A, Gram M, Mori M, Egesten A.

BMC Pulm Med. 2015 Mar 7;15:19. doi: 10.1186/s12890-015-0016-0.

34.

Interferon-λ: Inters Ferocity or Inter-Ferocities?

Egesten A, Herwald H.

J Innate Immun. 2015;7(3):223. doi: 10.1159/000381250. Epub 2015 Mar 24. No abstract available.

35.

All that glisters is not gold - Staphylococcus aureus and innate immunity.

Herwald H, Egesten A.

J Innate Immun. 2015;7(2):113-5. doi: 10.1159/000371822. Epub 2015 Jan 12. No abstract available.

36.

Osteopontin is increased in cystic fibrosis and can skew the functional balance between ELR-positive and ELR-negative CXC-chemokines.

Jovic S, Shikhagaie M, Mörgelin M, Erjefält JS, Kjellström S, Egesten A.

J Cyst Fibros. 2015 Jul;14(4):453-63. doi: 10.1016/j.jcf.2014.11.010. Epub 2014 Dec 6.

37.

Eotaxin-3 (CCL26) exerts innate host defense activities that are modulated by mast cell proteases.

Gela A, Kasetty G, Jovic S, Ekoff M, Nilsson G, Mörgelin M, Kjellström S, Pease JE, Schmidtchen A, Egesten A.

Allergy. 2015 Feb;70(2):161-70. doi: 10.1111/all.12542.

38.

Chasing flies because time flies.

Herwald H, Egesten A.

J Innate Immun. 2015;7(1):1-2. doi: 10.1159/000368704. Epub 2014 Oct 25. No abstract available.

39.

The Janus face of macrophages in immunity.

Herwald H, Egesten A.

J Innate Immun. 2014;6(6):713-5. doi: 10.1159/000367718. Epub 2014 Sep 10. No abstract available.

40.

Expression of MIG/CXCL9 in cystic fibrosis and modulation of its activities by elastase of Pseudomonas aeruginosa.

Jovic S, Shikhagaie M, Mörgelin M, Kjellström S, Erjefalt J, Olin AI, Frick IM, Egesten A.

J Innate Immun. 2014;6(6):846-59. doi: 10.1159/000365399. Epub 2014 Aug 9.

41.

A farewell to arms: streptococcal strategies to cope with innate immunity.

Herwald H, Egesten A.

J Innate Immun. 2014;6(5):561-2. doi: 10.1159/000363749. Epub 2014 Jun 25. No abstract available.

42.

Unexpected and novel functions of complement proteins.

Herwald H, Egesten A.

J Innate Immun. 2014;6(4):405-6. doi: 10.1159/000363198. Epub 2014 May 20. No abstract available.

43.

Increased incidence of invasive bacterial disease in chronic obstructive pulmonary disease compared to the general population--a population based cohort study.

Inghammar M, Engström G, Ljungberg B, Löfdahl CG, Roth A, Egesten A.

BMC Infect Dis. 2014 Mar 25;14:163. doi: 10.1186/1471-2334-14-163.

44.

Surveillance and countermeasures in innate immunity.

Herwald H, Egesten A.

J Innate Immun. 2014;6(1):1-2. No abstract available.

45.

Surveillance and Countermeasures in Innate Immunity.

Herwald H, Egesten A.

J Innate Immun. 2013 Dec 17. [Epub ahead of print] No abstract available.

46.

Macrophages: past, present and future.

Herwald H, Egesten A.

J Innate Immun. 2013;5(6):657-8. doi: 10.1159/000356293. Epub 2013 Oct 26. No abstract available.

47.

Midkine is expressed and differentially processed during chronic obstructive pulmonary disease exacerbations and ventilator-associated pneumonia associated with Staphylococcus aureus infection.

Linge HM, Andersson C, Nordin SL, Olin AI, Petersson AC, Mörgelin M, Welin A, Bylund J, Bjermer L, Erjefält J, Egesten A.

Mol Med. 2013 Sep 30;19:314-23. doi: 10.2119/molmed.2013.00045.

48.

Midkine in host defence.

Gela A, Jovic S, Nordin SL, Egesten A.

Br J Pharmacol. 2014 Feb;171(4):859-69. doi: 10.1111/bph.12402. Review.

49.

High expression of midkine in the airways of patients with cystic fibrosis.

Nordin SL, Jovic S, Kurut A, Andersson C, Gela A, Bjartell A, Mörgelin M, Olin AI, Lund M, Egesten A.

Am J Respir Cell Mol Biol. 2013 Dec;49(6):935-42. doi: 10.1165/rcmb.2013-0106OC.

PMID:
23815177
50.

Human chemokines as antimicrobial peptides with direct parasiticidal effect on Leishmania mexicana in vitro.

Söbirk SK, Mörgelin M, Egesten A, Bates P, Shannon O, Collin M.

PLoS One. 2013;8(3):e58129. doi: 10.1371/journal.pone.0058129. Epub 2013 Mar 22.

Supplemental Content

Loading ...
Support Center